Journal for ImmunoTherapy of Cancer (Nov 2023)

413 IBR403, a novel small molecule, enables scalable manufacturing of HSC-derived natural killer cells for cancer immunotherapy

  • Nina Horowitz,
  • Shyama Chaganti,
  • Bauer LeSavage,
  • Stefanie Mauer,
  • James Liu,
  • Peretz Partensky,
  • Jesse Cotari

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0413
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.